Chapter 1 - The Nursing Process and Drug Therapy 3

Chapter 2 - Pharmacologic Principles 7

Chapter 3 - Lifespan Considerations 13

Chapter 4 - Cultural Legal and Ethical Considerations 19

Chapter 5 - Medication Errors Preventing and Responding 25

Chapter 6 - Patient Education and Drug Therapy 29

Chapter 7 - Over-the-Counter Drugs and Herbal and Dietary Supplements 34

Chapter 8 - Gene Therapy and Pharmacogenomics 38

Chapter 9 - Photo Atlas of Drug Administration 42

Chapter 10 - Analgesic Drugs 50

Chapter 11 - General and Local Anesthetics 57

Chapter 12 - Central Nervous System Depressants and Muscle Relaxants 61

Chapter 13 - Central Nervous System Stimulants and Related Drugs 66

Chapter 14 - Antiepileptic Drugs 70

Chapter 15 - Anti-Parkinson Drugs 75

Chapter 16 - Psychotherapeutic Drugs 80

Chapter 17 - Substance Use Disorder 87

Chapter 18 - Adrenergic Drugs 92

Chapter 19 - Adrenergic-Blocking Drugs 97

Chapter 20 - Cholinergic Drugs 102

Chapter 21 - Cholinergic-Blocking Drugs 107

Chapter 22 - Antihypertensive Drugs 112

Chapter 23 - Antianginal Drugs 118

Chapter 24 - Heart Failure Drugs 124

Chapter 25 - Antidysrhythmic Drugs 129

Chapter 26 - Coagulation Modifier Drugs 134

Chapter 27 - Antilipemic Drugs 140

Chapter 28 - Diuretic Drugs 145

Chapter 29 - Fluids and Electrolytes 151

Chapter 30 - Pituitary Drugs 157

Pharmacology and the Nursing Process 9th Edition 9780323529495

Chapter 31 - Thyroid and Antithyroid Drugs 161

Chapter 32 - Antidiabetic Drugs 166

Chapter 33 - Adrenal Drugs 174

Chapter 34 - Women’s Health Drugs 178

Chapter 35 - Men’s Health Drugs 185

Chapter 36 - Antihistamines Decongestants Antitussives and Expectorants 189

Chapter 37 - Respiratory Drugs 194

Chapter 38 - Antibiotics Part 1 199

Chapter 39 - Antibiotics Part 2 206

Chapter 40 - Antiviral Drugs 211

Chapter 41 - Antitubercular Drugs 216

Chapter 42 - Antifungal Drugs 221

Chapter 43 - Antimalarial Antiprotozoal and Anthelmintic Drugs 226

Chapter 44 - Anti-inflammatory and Antigout Drugs 231

Chapter 45 - Antineoplastic Drugs Part 1 Cancer Overview and Cell Cycle 236

Chapter 46 - Antineoplastic Drugs Part 2 Cell Cycle Nonspecific and Misc.

Drugs 242

Chapter 47 - Biologic Response–Modifying and Antirheumatic Drugs 247

Chapter 48 - Immunosuppressant Drugs 252

Chapter 49 - Immunizing Drugs 257

Chapter 50 - Acid-Controlling Drugs 262

Chapter 51 - Bowel Disorder Drugs 268

Chapter 52 - Antiemetic and Antinausea Drugs 275

Chapter 53 - Vitamins and Minerals 280

Chapter 54 - Anemia Drugs 286

Chapter 55 - Nutritional Supplements 292

Chapter 56 - Drugs 296

Chapter 57 - Ophthalmic Drugs 302

Chapter 58 - Otic Drugs 307

Chapter 01: The Nursing Process and Drug Therapy

Lilley: Pharmacology and the Nursing Process, 9th Edition

MULTIPLE CHOICE

1. The nurse is developing a human needs statement for a patient who has a new diagnosis of

heart failure. Identification of human needs statements occur with which of these

activities?

a. Collection of patient data

b. Administering interventions

c. Deciding on patient outcomes

d. Documenting the patient’s behavior

ANS: A

Identification of human needs occurs with the collection of patient data.

DIF: Cognitive Level: Understanding (Comprehension)

TOP: Nursing Process: Human Needs Statement

MSC: NCLEX: Safe and Effective Care Environment: Management of Care

2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was

busy and gave the medication 2 hours after the scheduled dose was due. What type of

problem does this represent?

a. “Right time”

b. “Right dose”

c. “Right route”

d. “Right medication”

ANS: A

“Right time” is correct because the medication was given more than 30 minutes after the

scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the

medication administration is scheduled. “Route” is incorrect because the route is not

affected. “Medication” is incorrect because the medication ordered will not change.

DIF: Cognitive Level: Applying (Application)

TOP: Nursing Process: Implementation

MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control

3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first

dose and documenting the patient’s therapeutic response to the medication. Which phase

of the nursing process do these actions illustrate?

a. Human needs statement

b. Planning

c. Implementation

d. Evaluation

ANS: D

Monitoring the patient’s progress, including the patient’s response to the medication, is

part of the evaluation phase. Planning, implementation, and human needs statement are not

illustrated by this example.

Chapter 1 - The Nursing Process and Drug Therapy